TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Verto Pharma AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
109
|
233
|
149 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
47
|
121
|
56 |
| EBITDA |
48
|
123
|
57 |
| Total assets |
536
|
535
|
438 |
| Current assets |
309
|
288
|
188 |
| Current liabilities |
111
|
76
|
40 |
| Equity capital |
404
|
433
|
374 |
| - share capital |
4
|
5
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
75.4%
|
80.9%
|
85.4% |
| Turnover per employee |
109
|
233
|
149 |
| Profit as a percentage of turnover |
43.1%
|
51.9%
|
37.6% |
| Return on assets (ROA) |
8.8%
|
22.6%
|
12.8% |
| Current ratio |
278.4%
|
378.9%
|
470.0% |
| Return on equity (ROE) |
11.6%
|
27.9%
|
15.0% |
| Change turnover |
-105
|
87
|
120 |
| Change turnover % |
-49%
|
60%
|
427% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.